TY - JOUR
T1 - Bassoon contributes to tau-seed propagation and neurotoxicity
AU - Martinez, Pablo
AU - Patel, Henika
AU - You, Yanwen
AU - Jury, Nur
AU - Perkins, Abigail
AU - Lee-Gosselin, Audrey
AU - Taylor, Xavier
AU - You, Yingjian
AU - Viana Di Prisco, Gonzalo
AU - Huang, Xiaoqing
AU - Dutta, Sayan
AU - Wijeratne, Aruna B.
AU - Redding-Ochoa, Javier
AU - Shahid, Syed Salman
AU - Codocedo, Juan F.
AU - Min, Sehong
AU - Landreth, Gary E.
AU - Mosley, Amber L.
AU - Wu, Yu Chien
AU - McKinzie, David L.
AU - Rochet, Jean Christophe
AU - Zhang, Jie
AU - Atwood, Brady K.
AU - Troncoso, Juan
AU - Lasagna-Reeves, Cristian A.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Tau aggregation is a defining histopathological feature of Alzheimer’s disease and other tauopathies. However, the cellular mechanisms involved in tau propagation remain unclear. Here, we performed an unbiased quantitative proteomic study to identify proteins that specifically interact with this tau seed. We identified Bassoon (BSN), a presynaptic scaffolding protein, as an interactor of the tau seed isolated from a mouse model of tauopathy, and from Alzheimer’s disease and progressive supranuclear palsy postmortem samples. We show that BSN exacerbates tau seeding and toxicity in both mouse and Drosophila models for tauopathy, and that BSN downregulation decreases tau spreading and overall disease pathology, rescuing synaptic and behavioral impairments and reducing brain atrophy. Our findings improve the understanding of how tau seeds can be stabilized by interactors such as BSN. Inhibiting tau-seed interactions is a potential new therapeutic approach for neurodegenerative tauopathies.
AB - Tau aggregation is a defining histopathological feature of Alzheimer’s disease and other tauopathies. However, the cellular mechanisms involved in tau propagation remain unclear. Here, we performed an unbiased quantitative proteomic study to identify proteins that specifically interact with this tau seed. We identified Bassoon (BSN), a presynaptic scaffolding protein, as an interactor of the tau seed isolated from a mouse model of tauopathy, and from Alzheimer’s disease and progressive supranuclear palsy postmortem samples. We show that BSN exacerbates tau seeding and toxicity in both mouse and Drosophila models for tauopathy, and that BSN downregulation decreases tau spreading and overall disease pathology, rescuing synaptic and behavioral impairments and reducing brain atrophy. Our findings improve the understanding of how tau seeds can be stabilized by interactors such as BSN. Inhibiting tau-seed interactions is a potential new therapeutic approach for neurodegenerative tauopathies.
UR - https://www.scopus.com/pages/publications/85141421255
UR - https://www.scopus.com/pages/publications/85141421255#tab=citedBy
U2 - 10.1038/s41593-022-01191-6
DO - 10.1038/s41593-022-01191-6
M3 - Article
C2 - 36344699
AN - SCOPUS:85141421255
SN - 1097-6256
VL - 25
SP - 1597
EP - 1607
JO - Nature neuroscience
JF - Nature neuroscience
IS - 12
ER -